BSE Circulars (21849)
Bombay Stock Exchange circulars covering trading rules, listing requirements, compliance guidelines, market operations, and regulatory changes for market participants.
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE mandates a minimum 75% margin on equity and equity derivatives positions for securities with high promoter and non-promoter encumbrance … | |||||||||||||||
BSE mandates a minimum 75% margin on equity and equity derivatives positions for securities with high promoter and non-promoter encumbrance under SEBI (SAST) Regulation 2011, effective April 28, 2026. Securities eligible for exit from the framework are also listed.
| |||||||||||||||
BSE lists new shares issued by 7 companies under Employee Stock Option Plans (ESOP/ESOS), effective for trading from April 24, 2026. … | |||||||||||||||
BSE lists new shares issued by 7 companies under Employee Stock Option Plans (ESOP/ESOS), effective for trading from April 24, 2026. Companies include Axis Bank, CG Power, Federal Bank, and others.
| |||||||||||||||
BSE announces inclusion of securities under ST-ASM Stage I and Stage II with enhanced margin requirements effective April 27, 2026, as part … | |||||||||||||||
BSE announces inclusion of securities under ST-ASM Stage I and Stage II with enhanced margin requirements effective April 27, 2026, as part of the exchange's ongoing market surveillance framework.
| |||||||||||||||
BSE notifies trading members that debt securities of Logix Buildtech Pvt Ltd (Scrip Code 960193) will be available for trading with revised … | |||||||||||||||
BSE notifies trading members that debt securities of Logix Buildtech Pvt Ltd (Scrip Code 960193) will be available for trading with revised terms effective April 24, 2026, including updated ISIN, scrip name, and maturity date.
| |||||||||||||||
BSE revises price bands for 29+ scrips effective April 24, 2026, with bands set to 2%, 5%, or 10% for various equity securities. | |||||||||||||||
BSE revises price bands for 29+ scrips effective April 24, 2026, with bands set to 2%, 5%, or 10% for various equity securities.
| |||||||||||||||
BSE notifies trading members that New Markets Advisory Ltd (scrip code 508867) will change its name to New Markets Avenue Limited effective … | |||||||||||||||
BSE notifies trading members that New Markets Advisory Ltd (scrip code 508867) will change its name to New Markets Avenue Limited effective April 29, 2026, with updated SCRIP ID and abbreviated name NEWMKTAVE on BOLT Plus system.
| |||||||||||||||
BSE announces the Offer to Buy (Buyback) acquisition window schedule for Aurobindo Pharma Ltd (AUROPHARMA), open from April 23 to April 29, … | |||||||||||||||
BSE announces the Offer to Buy (Buyback) acquisition window schedule for Aurobindo Pharma Ltd (AUROPHARMA), open from April 23 to April 29, 2026, at an offer price of Rs. 1475 per share for up to 54,23,728 equity shares.
| |||||||||||||||
BSE cancels the proposed shifting of Eraaya Lifespaces Ltd and Vikas Lifecare Ltd to the 'Z' group, which was earlier announced via Notice … | |||||||||||||||
BSE cancels the proposed shifting of Eraaya Lifespaces Ltd and Vikas Lifecare Ltd to the 'Z' group, which was earlier announced via Notice No. 20260415-13 dated April 15, 2026, effective April 27, 2026.
| |||||||||||||||
BSE announces index reconstitution across 30+ indices effective April 30, 2026, as Vedanta Ltd. (500295) demerges its Aluminium, Merchant … | |||||||||||||||
BSE announces index reconstitution across 30+ indices effective April 30, 2026, as Vedanta Ltd. (500295) demerges its Aluminium, Merchant Power, Oil & Gas, and Iron Ore businesses. Vedanta will be dropped and replaced by Tata Motors, Hero Motocorp, or JM Financial depending on the index.
| |||||||||||||||
BSE Surveillance sought clarifications from Amara Raja Energy & Mobility Ltd and Dr Reddys Laboratories Ltd regarding news articles. Reply … | |||||||||||||||
BSE Surveillance sought clarifications from Amara Raja Energy & Mobility Ltd and Dr Reddys Laboratories Ltd regarding news articles. Reply received from Amara Raja; Dr Reddys reply is still awaited.
| |||||||||||||||